Write your message
Volume 18, Issue 4 (Iranian Journal of Breast Diseases 2026)                   ijbd 2026, 18(4): 24-39 | Back to browse issues page

Ethics code: IR.KMU.AH.REC.1402.083

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Dehesh P, Kalantari-Khandani B, Momeni M, Danaei M, Sadeghi Gughari F. Assessment of Medication Adherence and Its Relationship with Disease Uncertainty and Socioeconomic Factors in Patients with Breast Cancer. ijbd 2026; 18 (4) :24-39
URL: http://ijbd.ir/article-1-1183-en.html
1- Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
2- Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
3- Department of Oncology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
4- Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran , danaei.mina@gmail.com
5- Student Research Committee, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
Abstract:   (228 Views)
Introduction: Cancer treatment is often associated with various complications. Medication adherence is influenced by numerous psychological, demographic, socioeconomic, and disease-related factors. This study aimed to evaluate the status of medication adherence and the factors affecting it in patients with breast cancer in Kerman, Iran.
Methods: This cross-sectional study included patients with breast cancer who were followed up at a private oncology specialist's office and Javadalaimeh Clinic in Kerman, Iran, in 2024. Data were collected using a three-part questionnaire comprising demographic and treatment-related characteristics, the Medication Adherence Rating Scale (MARS), and the Mishel Uncertainty in Illness Scale.
Results: The mean MARS score was 7.44 ± 1.93, and 161 of 234 participants (68.8%) demonstrated high medication adherence. Higher illness uncertainty (P < 0.001) and family income below the subsistence level (P = 0.017) were significantly associated with lower medication adherence. Illness uncertainty was the strongest predictor of reduced medication adherence.
Conclusion: Although most patients with breast cancer exhibited high medication adherence, greater illness uncertainty and lower family income were significantly associated with lower adherence. These findings highlight the importance of addressing psychological and socioeconomic factors to improve medication adherence in this population.
Full-Text [PDF 625 kb]   (146 Downloads)    
Type of Study: Applicable | Subject: prevention
Received: 2025/04/28 | Accepted: 2025/12/21 | Published: 2026/01/14

References
1. Danaei M, Haghdoost A, Momeni M. An Epidemiological Review of Common Cancers in Iran; A Review Article. Iranian Journal of Blood and Cancer 2019; 11 (3):77-84.
2. Tzenios N, Tazanios ME, Chahine M. The impact of BMI on breast cancer-an updated systematic review and meta-analysis.Medicine. 2024 ;103(5):e36831.doi: 10.1097/MD.0000000000036831. [DOI:10.1097/MD.0000000000036831] [PMID] []
3. Sanaat Z, Dolatkhah R. Epidemiologic profile of breast cancer in Iran: a systematic review and meta-analysis. Clinical Epidemiology and Global Health. 2024 1;26:101537. doi:10.1016/j.cegh.2024.101537 [DOI:10.1016/j.cegh.2024.101537]
4. Sajjadi M, Rassouli M, Abbaszadeh A, Alavi Majd H, Zendehde K. Translation and validation of the "Uncertainty in Illness Scale" in Iranian Patients with Cancer. Payesh. 2015; 14(1) :101-10. (Persian)
5. Samiee V, Karimi Q, Akbari M. Evaluation of the causal model of adjustment to the disease based on uncertainty and cognitive flexibility in women with breast cancer with a mediating role of difficulty in emotion regulation. Rooyesh-e-Ravanshenasi Journal (RRJ). 2023 ;12(1):63-74.(Persian)
6. Chen LW, Chou HH, Wang SY, Shih WM. Unmet Care Needs and Uncertainty in Patients Newly Diagnosed with Breast Cancer. Healthcare (Basel). 2022;10(11):2148. doi: 10.3390/healthcare10112148. [DOI:10.3390/healthcare10112148] [PMID] []
7. Davoodi M, Amini M, Manzari Z. The lived experience of the uncertainty of the disease in patients with Covid-19; A phenomenological study. Journal of Torbat Heydariyeh University of Medical Sciences. 2023;11(1):48-60. (Persian)
8. Mohammadi E, Aminorroaya A, Fattahi N, Azadnajafabad S, Rezaei N, Farzi Y, et al. Epidemiologic pattern of cancers in Iran; current knowledge and future perspective. J Diabetes Metab Disord. 2021;20(1):825-9. doi: 10.1007/s40200-020-00654-6. [DOI:10.1007/s40200-020-00654-6] [PMID] []
9. Koohestani HR, Baghcheghi N. The Relationship Between the Use of Medicinal Plants and Medication Adherence in the Elderly with Chronic Diseases. Iranian Journal of Ageing. 2022 Jul 10;17(2):276-89. [DOI:10.32598/sija.2022.3247.1]
10. Farshidfar Z, Rahimian-Booger I, Asadi J, Izadpanahi P. The effectiveness of group-based behavioral activation therapy on adherence to treatment of women with breast cancer. Feyz Medical Sciences Journal. 2019;23(5):511-20. (Persian)
11. Souliotis K, Peppou LE, Economou M, Marioli A, Nikolaidi S, Saridi M, et al. Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians. Asian Pac J Cancer Prev. 2021;22(6):1891-98. doi: 10.31557/APJCP.2021.22.6.1891. [DOI:10.31557/APJCP.2021.22.6.1891] [PMID] []
12. Chou W-C, Chen J-S, Hung C-Y, Lu C-H, Shao Y-Y, Chiou T-J, et al. A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life. Supportive Care in Cancer. 2019;27:2857-67. doi: 10.1007/s00520-018-4599-x. [DOI:10.1007/s00520-018-4599-x] [PMID]
13. Paranjpe R, John G, Trivedi M, Abughosh S. Identifying adherence barriers to oral endocrine therapy among breast cancer survivors. Breast Cancer Research and Treatment. 2019;174:297-305. doi: 10.1007/s10549-018-05073-z. [DOI:10.1007/s10549-018-05073-z] [PMID]
14. Sajjadi M, Mohammadpour A, Mahmoudi M. Correlation between Uncertainty in the illness, demographic and clinical factors with adherence to treatment in patients with cancer. Journal of Sabzevar University of Medical Sciences. 2017;24(3):205-10. (Persian)
15. Babaie E, Goodarzi L, Hossini ST. The Effectiveness of Positive Psychotherapy on the Treatment Adherence of Chronic Breast Cancer Patients. Health Psychology. 2024;12(48):101-12. (Persian)
16. Abbaszadeh M, Rejeh N, Tadrisi S D, jafari F. Medication Adherence in Patients Undergoing Repeat Angioplasty: A Cross-sectional Study. Jccnursing. 2021; 14(4) :41-50.. (Persian)
17. Thompson A, Kulkarni, J. Sergejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia research. 2000; 42(3), 241-47. doi:10.1016/S0920-9964(99)00130-9. [DOI:10.1016/S0920-9964(99)00130-9] [PMID]
18. Allahbakhshian A, Gholizadeh L. Is beliefs about medication a factor in adherence to the medicine in patients undergoing coronary angioplasty?. Crescent Journal of Medical and Biological Sciences.2020:7(3): 414 -20 .
19. Sajjadi M, Rassouli M, Abbaszadeh A, Alavi Majd H, Zendehdel K. Psychometric properties of the Persian version of the Mishel's Uncertainty in Illness Scale in patients with cancer. Eur J Oncol Nurs. 2014;18(1):52-7. doi: 10.1016/j.ejon.2013.09.006. [DOI:10.1016/j.ejon.2013.09.006] [PMID]
20. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3(1):17. doi: 10.1186/1751-0473-3-17. [DOI:10.1186/1751-0473-3-17] [PMID] []
21. Pourcelot C, Orillard E, Nallet G, Dirand C, Billion-Rey F, Barbier G, et al. Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence. Breast Cancer Research and Treatment. 2018;169:153-62. doi: 10.1007/s10549-018-4676-3. [DOI:10.1007/s10549-018-4676-3] [PMID]
22. Dragvoll I, Bofin AM, Søiland H, Taraldsen G, Engstrøm MJ. Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer. BMC cancer. 2022;22(1):1247. doi: 10.1186/s12885-022-10362-4. [DOI:10.1186/s12885-022-10362-4] [PMID] []
23. Brett J, Fenlon D, Boulton M, Hulbert‐Williams NJ, Walter FM, Donnelly P, et al. Factors associated with intentional and unintentional non‐adherence to adjuvant endocrine therapy following breast cancer. European journal of cancer care. 2018;27(1):e12601 doi: 10.1111/ecc.12601. [DOI:10.1111/ecc.12601] [PMID]
24. Puts MTE, Tu HA, Tourangeau A, Howell D, Fitch M, Springall E , et al. Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. Annals of Oncology, 2013: 1-14. doi: 10.1093/annonc/mdt433. [DOI:10.1093/annonc/mdt433] [PMID] []
25. Rouhi Balasi L, Paryad E, Kazemnezhad Leili E, Booraki SH, SadeghiMeibodi AM, Nasiri Sheikhani N. Study status of care adherence and its related factors in patients undergoing Coronary Artery Bypass Surgery. Journal of Holist Nursing. 2013;25(77):34-45. (Persian)
26. Gholamaliei B, Karimi-Shahanjarini A, Roshanaei G, Rezapour-Shahkolaei F. Medication adherence and its related factors in patients with type II diabetes. Journal of Education and Community Health [internet]. 2016;2(4):3-12.(Persian) [DOI:10.21859/jech-02042]
27. Kleinsinger F. The unmet challenge of medication nonadherence. The Permanente Journal. 2018;22:18-33. doi: 10.7812/TPP/18-033. [DOI:10.7812/TPP/18-033] [PMID] []
28. Kvarnström K, Airaksinen M, Liira H. Barriers and facilitators to medication adherence: a qualitative study with general practitioners. BMJ open. 2018;8(1):e015332. doi: 10.1136/bmjopen-2016-015332. [DOI:10.1136/bmjopen-2016-015332] [PMID] []
29. Anurupa MS, Aditya A, Angadi N. A study of medication adherence and self-care practices among type-2 diabetes patients in Davangere. National Journal of Community Medicine. 2019;10(01):12-6.
30. Shen Z, Zhang L, Shi S, Ruan C, Dan L, Li C. The relationship between uncertainty and fear of disease progression among newly diagnosed cancer patients: the mediating role of intolerance of uncertainty. BMC psychiatry. 2024;24(1):756. doi: 10.1186/s12888-024-06201-4. [DOI:10.1186/s12888-024-06201-4] [PMID] []
31. Paranjpe R, John G, Trivedi M, Abughosh S. Identifying adherence barriers to oral endocrine therapy among breast cancer survivors. Breast Cancer Research and Treatment. 2019;174:297-305. doi: 10.1007/s10549-018-05073-z. [DOI:10.1007/s10549-018-05073-z] [PMID]
32. Puts M, Tu H, Tourangeau A, Howell D, Fitch M, Springall E, et al. Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. Annals of Oncology. 2014;25(3):564-77. doi: 10.1093/annonc/mdt433. [DOI:10.1093/annonc/mdt433] [PMID] []
33. Akkuş Y, Menekli T. Determining the Relationship Between Intolerance of Uncertainty and Attitudes Toward Complementary and Alternative Medicine in Patients With Cancer. Holistic Nursing Practice. 2023;37(5):277-84.doi: 10.1097/HNP.0000000000000600. [DOI:10.1097/HNP.0000000000000600] [PMID]
34. Ali Z, Rizwan M. Impact of Illness Uncertainty on Quality of Life in Breast Cancer Patients: Mediating Role of Social Support. JHWCR [Internet]. 2025 [cited 2025 Sep. 13];:e286. doi:10.61919/786b7y07 [DOI:10.61919/786b7y07]
35. Alessy SA, Alqahtani SA, Vignat J, Abuhmaidan A, Basmi AE, Al Lawati N, et al. The current and future cancer burden in the Gulf Cooperation Council (GCC) countries. Cancer Med. 2024;13(17):e70141.doi: 10.1002/cam4.70141. [DOI:10.1002/cam4.70141] [PMID] []

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Iranian Journal of Breast Diseases

Designed & Developed by: Yektaweb